1272. Feasibility and Successful Enrollment in Proof-of-Concept Trials to Assess Safety and Efficacy of a Broadly Neutralizing Monoclonal Antibody, VRC01, to Prevent HIV-1 Acquisitionin in Uninfected Individuals

BACKGROUND: The Antibody-mediated Prevention (AMP) trials (HVTN 704/HPTN 085 and HVTN 703/HPTN 081) are the first efficacy trials to evaluate whether VRC01, a broadly neutralizing antibody (bnAb) that targets CD4 binding site of HIV envelope, prevents HIV acquisition in uninfected individuals. In th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Edupuganti, Srilatha, Mgodi, Nyaradzo M, Karuna, Shelly, Andrew, Philip, Kochar, Nidhi, Marshall, Kyle, Decamp, Allan, Takuva, Simbarashe, Anderson, Maija, De La Grecca, Robert, Gomez Lorenzo, Margarita, Burns, David, Goepfert, Paul, McElrath, Julie, Casapia, Martin, Sanchez, Jorge, Mukwekwerere, Pamela G, Shava, Emily, Lazarus, Erica M, Hural, John, Mascola, John R, Cohen, Myron, Corey, Lawrence
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6808666/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1135
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados